STRATA Skin Sciences to Participate at Upcoming Investor Conferences

Rhea-AI Summary

STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced its participation in two upcoming investor events: the Microcap Rodeo: Windy City Roundup 2022 on October 12, 2022, and the LD Micro Main Event XV on October 26, 2022. At these events, the company will showcase its innovative dermatology products, including the XTRAC^® and TheraClear^® systems, which target conditions like psoriasis, acne, and vitiligo, impacting over 31 million patients in the U.S. STRATA employs a unique Direct to Consumer advertising model to boost awareness and patient volume for its partner dermatology clinics.

HORSHAM, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will present at the Midcap Rodeo: Windy City Roundup 2022 and the LD Micro Main Event XV.

Microcap Rodeo: Windy City Roundup 2022
Date: Wednesday, October 12, 2022
Time: 3:00 PM CDT
For more information, please visit the events webpage, here.

LD Micro Main Event XV
Date: Wednesday, October 26, 2022
Time: 12:30 PM PDT
Virtual Viewers: Livestream

About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the in-office treatment of dermatologic conditions. Its products include the XTRAC^®, XTRAC Momentum™ 1.0 and Pharos^® excimer lasers, VTRAC^® lamp systems, and TheraClear^® treatment systems utilized in the treatment of psoriasis, vitiligo, acne and various other skin conditions.

The Company’s proprietary XTRAC^® and XTRAC Momentum™ 1.0 excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. In addition, STRATA's TheraClear^®X, utilizes FDA-Cleared technology to address the estimated $5.5 billion market opportunity for acne treatment with a non-invasive, highly effective, in-office procedure.

STRATA’s unique business model, in the U.S., leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.

Investor Contact:
Rich Cockrell
CG Capital
Phone: +1 (404) 736-3838
Email: sskn@cg.capital

FAQ

What is STRATA Skin Sciences, Inc. (SSKN) known for?

STRATA Skin Sciences, Inc. is known for developing innovative medical technology products for dermatologic conditions, including treatments for psoriasis and acne.

When will STRATA Skin Sciences present at the Microcap Rodeo event?

STRATA Skin Sciences will present at the Microcap Rodeo: Windy City Roundup 2022 on October 12, 2022.

What time is STRATA's presentation at the LD Micro Main Event XV?

STRATA Skin Sciences will present at the LD Micro Main Event XV on October 26, 2022, at 12:30 PM PDT.

What products does STRATA Skin Sciences offer for dermatologic treatments?

STRATA offers products including the XTRAC^®, XTRAC Momentum™ 1.0, Pharos^® lasers, and TheraClear^® treatment systems.

How does STRATA Skin Sciences target acne treatment in the market?

STRATA's TheraClear^®X utilizes FDA-Cleared technology to provide an effective non-invasive treatment for acne, addressing a $5.5 billion market opportunity.